Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
about
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled TrialsTopical therapy for acne vulgaris. How do you choose the best drug for each patient?Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndromeAn Association Study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in Women with Polycystic Ovary Syndrome from West Azerbaijan Province, IranInsulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or ObesityInsulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome.Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice.Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict circulating sex hormone-binding globulin in premenopausal womenGreek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.An internet-based prospective study of body size and time-to-pregnancy.Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.Reflections on inositol(s) for PCOS therapy: steps toward success.Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe?A mass spectrometric insight into the origins of benign gynecological disorders.Conserved insulin signaling in the regulation of oocyte growth, development, and maturation.Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome.Effects of exercise and nutritional counseling in women with polycystic ovary syndrome.Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials.Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions.High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model.Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome.Elevated circulating levels of xenopsin-related peptide-1 are associated with polycystic ovary syndrome.Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study.Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome.High-Fat, High-Sugar Diet Disrupts the Preovulatory Hormone Surge and Induces Cystic Ovaries in Cycling Female Rats.
P2860
Q28073603-BA71872C-E95C-447C-B398-534B9CE507CBQ33869762-6EE9CB81-E6EA-436E-AF90-E0634C9F2C90Q34011105-BB7DFCF5-BE75-428F-AC16-0CCEFD389A28Q34153910-30358583-FBA5-40D4-A112-6974DE6E3EA8Q34226362-B202BEDE-8922-4C0E-92AD-3B29F0E4EC0AQ35064005-74385CAD-B5BA-47EF-A74D-D9F42D141FA7Q35117211-2626372B-889D-4FFC-BFD5-6DC2F673AC8FQ35276405-A7F71383-B41F-43D9-850F-0E7A16DEE3DFQ35599772-EFD430B7-5327-4B55-9C6A-E4E93145DC61Q35675962-09FC388D-D9DA-4025-9F81-A46FA56F1910Q35744483-A2C0EC86-6395-4CB3-887A-A89182454B62Q36182579-4E1B9D34-0F75-4430-8878-A61E1A50F481Q36328060-F547F0CF-8D72-453E-9990-8C91EB64B50FQ36517626-06F52301-544A-450F-AA77-E7EF92075C18Q36951616-B3E8F35D-EF84-4CC1-8A8F-3ED169B1AB61Q37091345-F9B19DC4-6617-46CB-AB58-9A6275D31991Q37132257-27132A86-4C42-404B-9B0C-6B273E170442Q37194439-388F7733-6BF5-4754-9F87-DFB6F7BCD4C9Q37310914-4581261B-7EED-4354-8B3C-D9796E2CAFDAQ37355732-473BB3D0-70A2-4C59-923C-B14D415345CAQ37479057-A36FC98D-1DF1-432A-92DE-814CDC485C90Q37690022-9AAD4058-7E30-41BE-8875-F7EDFE5D8518Q38217670-644DC95C-6249-4C43-B48C-FA266D0B4286Q38547588-37398CF9-BB04-455C-B8B5-400FE4237C05Q38569482-A3B16F20-C929-4145-B90D-410CB1A2A76CQ38657980-D5C8C3C6-44A7-406A-9188-7CEA7C02564DQ38852970-B2B35AED-4F2D-4DCE-BF11-2B60FDA5D555Q41653290-83C0825F-D06E-4C1D-B9AC-5A7FF0CC6845Q42499530-28809723-B765-43E8-A481-E3DAC77B75CFQ42635246-45854A02-B10E-4DC4-8324-203118687370Q43276009-66B221D7-F717-4E95-A589-924DA303FBE4Q44118719-551A454F-6FC5-46D5-8E18-50DD84E53EB2Q44859933-5A93839D-4180-43C8-923F-876F5101873BQ45052801-7DD86E41-5C2F-4033-93F7-0213F324D54DQ45205632-90C31E75-B6E6-4F0F-A956-E2E9A0DBBBE3Q47918685-60C331E4-2485-484E-9E33-CD191C3E3245Q50075637-4CECE9B1-EC5E-46FD-BC82-43D47507DED7Q51295208-045E326E-B4B6-4751-93E6-23CED9F1C5BFQ55095950-52C057C0-DA94-43FF-BBDA-A6FDEB689391
P2860
Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Role of hyperinsulinemia in th ...... and its clinical implications.
@en
type
label
Role of hyperinsulinemia in th ...... and its clinical implications.
@en
prefLabel
Role of hyperinsulinemia in th ...... and its clinical implications.
@en
P356
P1476
Role of hyperinsulinemia in th ...... and its clinical implications.
@en
P2093
J E Nestler
P304
P356
10.1055/S-2007-1016294
P577
1997-05-01T00:00:00Z